title: The case for lamotrigine monitoring in pregnancy.
authors.affiliation: Australian Raoul Wallenberg Centre for Clinical Neuropharmacology, University of Melbourne, Monash University, and University of Queensland, Australia. vajda@ozemail.com.au
authors.forename: F
authors.initials: F
authors.lastname: Vajda
authors.forename: C
authors.initials: C
authors.lastname: Solinas
authors.forename: J
authors.initials: J
authors.lastname: Graham
authors.forename: A
authors.initials: A
authors.lastname: Hitchcock
authors.forename: M
authors.initials: M
authors.lastname: Eadie
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D008991:Monitoring, Physiologic; D011247:Pregnancy; D014227:Triazines / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine